Orthometrix, Inc.
OMRX · OTC
12/31/2014 | 12/31/2013 | 12/31/2012 | 12/31/2007 | |
|---|---|---|---|---|
| Revenue | $1,530 | $1,072 | $651 | $2,410 |
| % Growth | 42.7% | 64.8% | -73% | – |
| Cost of Goods Sold | $465 | $332 | $249 | $1,339 |
| Gross Profit | $1,065 | $740 | $402 | $1,070 |
| % Margin | 69.6% | 69% | 61.7% | 44.4% |
| R&D Expenses | $0 | $0 | $0 | $6 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $801 | $612 | $546 | $1,480 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$832 |
| Operating Expenses | $801 | $612 | $546 | $654 |
| Operating Income | $263 | $128 | -$144 | $416 |
| % Margin | 17.2% | 11.9% | -22.1% | 17.3% |
| Other Income/Exp. Net | $153 | -$70 | -$69 | -$660 |
| Pre-Tax Income | $416 | $58 | -$213 | $0 |
| Tax Expense | $0 | $0 | $18 | $0 |
| Net Income | $416 | $58 | -$231 | -$1,076 |
| % Margin | 27.2% | 5.4% | -35.4% | -44.7% |
| EPS | 0.008 | 0.001 | -0.004 | -0.02 |
| % Growth | 609.1% | 125% | 78% | – |
| EPS Diluted | 0.008 | 0.001 | -0.004 | -0.02 |
| Weighted Avg Shares Out | 53,209 | 53,007 | 53,007 | 45,233 |
| Weighted Avg Shares Out Dil | 53,209 | 53,007 | 53,007 | 45,233 |
| Supplemental Information | – | – | – | – |
| Interest Income | $12 | $1 | $0 | $0 |
| Interest Expense | $69 | $71 | $69 | $654 |
| Depreciation & Amortization | $1 | $1 | $4 | $20 |
| EBITDA | $486 | $130 | -$140 | -$396 |
| % Margin | 31.8% | 12.1% | -21.5% | -16.4% |